木香Aucklandiae Radix作为兼具药用与香料价值的传统植物资源，其资源分布、开发利用及国际贸易格局呈现显著的区域特征与产业升级趋势。系统梳理木香品种沿革与亚洲传统药用体系应用特征，总结木香相关产品开发现状及技术瓶颈，对比各国木香质量控制标准，分析其国际贸易数据与发展趋势，为木香资源的可持续利用、产品高值化开发及国际贸易布局提供理论参考与实践思路。总结分析发现，木香易混品多不能替代使用，资源以人工栽培为主，中国云南、四川、重庆为核心产区；医疗应用方面，我国中医药、印度医学、东南亚民间医药等均有应用，其行气止痛、健脾消食等核心功效得到广泛应用；当前木香产品开发已从传统药材向高附加值产品如提取物、中成药、保健品、化妆品、兽药等延伸，产业链不断完善；各国质量标准在检测指标限量要求上存在差异，欧洲、英国、中国、韩国药典比较重视农药以及重金属等方面的限度控制，日本、越南、印度对木香中主要成分含量测定不作规定；国际贸易方面，木香形成以亚洲为核心的产销网络。同时，木香产业也面临资源退化、加工技术参差不齐、国际标准衔接不畅等问题。

As a traditional plant resource with both medicinal and aromatic value, Muxiang (Aucklandiae Radix) exhibits distinct regional characteristics and trends of industrial upgrading of resource distribution, development and utilization, and international trade patterns. This paper systematically reviews the evolution of Aucklandiae Radix varieties and their application characteristics in Asian traditional medical systems, summary of the current development status and technical bottlenecks of Aucklandiae Radix-related products, compares quality control standards across countries, and analyzes international trade data and development trends to provide theoretical references and practical ideas for the sustainable utilization of Aucklandiae Radix resources, high-value product development, and international trade layout. The results indicate that there are numerous adulterants of Aucklandiae Radix cannot be used interchangeably; resources are primarily derived from artificial cultivation, with Yunnan, Sichuan, and Chongqing in China serving as core production areas. In terms of medical applications, it is utilized in traditional Chinese medicine, Indian medicine, and Southeast Asian folk medicine, with its core functions of promoting qi circulation to relieve pain and strengthening the spleen to aid digestion being widely applied. Currently, Aucklandiae Radix product development has extended from traditional herbal materials to high-value-added extracts, traditional Chinese patent medicines, health supplements, cosmetics, and veterinary drugs, with the industrial chain continuously improving. There are differences in quality standards across countries regarding detection indicators and limit requirements; pharmacopoeias in Europe, British, China, and South Korea emphasize limits on pesticides and heavy metals, whereas Japan, Vietnam, and India do not specify requirements for the determination of major component content. In terms of internationalrade, Aucklandiae Radix has formed a production and sales network centered on Asia. Meanwhile, the Aucklandiae Radix industry faces challenges such as resource degradation, uneven processing technology, and poor alignment of international standards. This paper provides theoretical references and practical ideas for the sustainable utilization of Aucklandiae Radix resources, high-value product development, and international trade layout.

R282.71

云南省中药防治代谢综合征创新团队（202505AS350014）；澜湄区域资源创新药物研究与开发云南省教育厅工程研究中心（2022YGG03）；云南省中国-老挝传统医药国际联合实验室（202503AP140023）